Linical Company Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Linical Company Limited with three other
companies in this sector in JAPAN :
Morishita Jintan Co., Ltd.
sales of 9.77 billion Japanese Yen [US$93.54 million]
of which 75%
was Health Care Business),
Shin Nippon Biomedical Laboratories Ltd
(14.56 billion Japanese Yen [US$139.35 million]
of which 90%
was Pre-Clinical Business), and
Japan Tissue Engineering Company Limited
(2.31 billion Japanese Yen [US$22.11 million]
of which 59%
was Regenerative Medicine Products Business).
Linical Company Limited reported sales of ¥10.94 billion (US$104.65 million)
March of 2020.
decrease of 3.3%
versus 2019, when the company's sales were ¥11.31 billion.
Contributing to the drop in overall sales was the 4.4% decline
in Cro Business, from ¥10.36 billion to ¥9.90 billion.
However, these declines were partially offset by the increase in sales of
Cso Project (up 8.2% to ¥1.03 billion)